These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30498397)

  • 1. Biological indicators of chemoresistance: an ex vivo analysis of γH2AX and
    Bing Y; Wund Z; Abratte T; Borlle L; Kang S; Southard T; Hume KR
    Cancer Cell Int; 2018; 18():192. PubMed ID: 30498397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage is a feature of feline injection-site sarcoma.
    Kang S; Southard T; Hume KR
    Vet Comp Oncol; 2017 Jun; 15(2):518-524. PubMed ID: 26781433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidating the transcriptional program of feline injection-site sarcoma using a cross-species mRNA-sequencing approach.
    Wei Q; Ramsey SA; Larson MK; Berlow NE; Ochola D; Shiprack C; Kashyap A; Séguin B; Keller C; Löhr CV
    BMC Cancer; 2019 Apr; 19(1):311. PubMed ID: 30947707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of MMP-2, MMP-9, COX-2, and PGP Expression in Feline Injection-Site and Feline Noninjection-Site Sarcomas-Pilot Study.
    Wojtkowska A; Małek A; Giziński S; Sapierzyński R; Rodo A; Sokołowska J; Zabielska-Koczywąs KA; Wojtalewicz A; Walewska M; Kautz E; Ostrzeszewicz M; Lechowski R
    Animals (Basel); 2024 Jul; 14(14):. PubMed ID: 39061572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenovirus-mediated p53 gene therapy in pediatric soft-tissue sarcoma cell lines: sensitization to cisplatin and doxorubicin.
    Ganjavi H; Gee M; Narendran A; Freedman MH; Malkin D
    Cancer Gene Ther; 2005 Apr; 12(4):397-406. PubMed ID: 15618970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wild type p53 sensitizes soft tissue sarcoma cells to doxorubicin by down-regulating multidrug resistance-1 expression.
    Zhan M; Yu D; Lang A; Li L; Pollock RE
    Cancer; 2001 Sep; 92(6):1556-66. PubMed ID: 11745235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of p53, fibroblast growth factor-b, and transforming growth factor-alpha in feline vaccine-associated sarcomas.
    Nieto A; Sánchez MA; Martínez E; Rollán E
    Vet Pathol; 2003 Nov; 40(6):651-8. PubMed ID: 14608018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic Differences in Feline Fibrosarcomas Grown Using Doxorubicin-Sensitive and -Resistant Cell Lines in the Chick Embryo Model.
    Zabielska-Koczywąs K; Michalak K; Wojtalewicz A; Winiarczyk M; Adaszek Ł; Winiarczyk S; Lechowski R
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29443940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
    Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
    Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Poty S; Mandleywala K; O'Neill E; Knight JC; Cornelissen B; Lewis JS
    Theranostics; 2020; 10(13):5802-5814. PubMed ID: 32483420
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticancer drug sensitivity and expression of multidrug resistance markers in early passage human sarcomas.
    Hoffmann J; Schmidt-Peter P; Hänsch W; Naundorf H; Bunge A; Becker M; Fichtner I
    Clin Cancer Res; 1999 Aug; 5(8):2198-204. PubMed ID: 10473106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous expression of phosphorylated histone H2AX in tumors in relation to DNA double-strand breaks and genomic instability.
    Yu T; MacPhail SH; Banáth JP; Klokov D; Olive PL
    DNA Repair (Amst); 2006 Aug; 5(8):935-46. PubMed ID: 16814620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of E-cadherin and p53 proteins in human soft tissue sarcomas.
    Yoo J; Park S; Kang CS; Kang SJ; Kim BK
    Arch Pathol Lab Med; 2002 Jan; 126(1):33-8. PubMed ID: 11800644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone receptor expression, clinical and histopathological analysis in feline injection site sarcomas.
    Zanuncio VV; Conceição LG; Loures FH; Cassali GD; Rocha K; Lima BM
    Vet Comp Oncol; 2021 Sep; 19(3):473-481. PubMed ID: 33211351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin Conjugated to Glutathione Stabilized Gold Nanoparticles (Au-GSH-Dox) as an Effective Therapeutic Agent for Feline Injection-Site Sarcomas-Chick Embryo Chorioallantoic Membrane Study.
    Zabielska-Koczywąs K; Dolka I; Król M; Żbikowski A; Lewandowski W; Mieczkowski J; Wójcik M; Lechowski R
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28208720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine xenograft model demonstrates significant radio-sensitising effect of liposomal doxorubicin in a combination therapy for Feline Injection Site Sarcoma.
    Petznek H; Kleiter M; Tichy A; Fuchs-Baumgartinger A; Hohenadl C
    Res Vet Sci; 2014 Oct; 97(2):386-90. PubMed ID: 25104320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of nuclear factor-kappa B in feline injection site sarcoma.
    Hsueh CS; Wu CH; Shih CH; Yeh JL; Jeng CR; Pang VF; Chiou HY; Chang HW
    BMC Vet Res; 2019 Oct; 15(1):365. PubMed ID: 31653220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of soft-tissue sarcomas resistance to the cytotoxic action of TNF-α by restoring p53 function.
    Muret J; Hasmim M; Stasik I; Jalil A; Mallavialle A; Nanbakhsh A; Lacroix L; Billot K; Baud V; Thiery J; Vielh P; Terrier P; Wiels J; Vassilev L; Lecesne A; Bonvalot S; Chouaib S
    PLoS One; 2012; 7(6):e38808. PubMed ID: 22719951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of Glutathione-Stabilized Gold Nanoparticles in Feline Fibrosarcomas and Their Role as a Drug Delivery System for Doxorubicin-Preclinical Studies in a Murine Model.
    Zabielska-Koczywąs K; Wojtalewicz A; Użarowska E; Klejman A; Wojtkowska A; Dolka I; Wojnicki M; Sobczak K; Wójcik M; Shen H; Ferrari M; Lechowski R
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29596317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
    Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.